Table 1.
Demographic summary for Asian subgroup (Full Analysis Set).
| PBO (N = 59) | LEM5 (N = 61) | LEM10 (N = 58) | Total (N = 178) | |
|---|---|---|---|---|
| Age, yearsa | ||||
| Mean (SD) | 53.1 (14.4) | 51.3 (14.0) | 50.3 (15.6) | 51.6 (14.6) |
| Median (range) | 53.0 (24–80) | 50.0 (20–76) | 51.0 (18–80) | 51.0 (18–80) |
| Sex, n (%) | ||||
| Male | 24 (40.7) | 29 (47.5) | 22 (37.9) | 75 (42.1) |
| Female | 35 (59.3) | 32 (52.5) | 36 (62.1) | 103 (57.9) |
| Race, n (%) | ||||
| Japanese | 54 (91.5) | 53 (86.9) | 54 (93.1) | 161 (90.4) |
| Chinese | 0 | 3 (4.9) | 1 (1.7) | 4 (2.2) |
| Other Asian | 5 (8.5) | 5 (8.2) | 3 (5.2) | 13 (7.3) |
| BMI, kg/m2, mean (SD) | 23.1 (3.7) | 22.7 (3.2) | 22.9 (3.5) | 22.9 (3.5) |
| ISI total score, mean (SD) | 17.9 (2.5) | 18.1 (2.9) | 18.1 (2.9) | 18.0 (2.7) |
Percentages are based on the total number of subjects with nonmissing values in the relevant treatment group.
BMI, body mass index; ISI, Insomnia Severity Index; LEM5, lemborexant 5 mg; LEM10, lemborexant 10 mg; PBO, placebo; SD, standard deviation.
a
Age is calculated at date of informed consent.